Lewis DF, Lake BG, Bird MG (June 2005). "Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity". Toxicology in Vitro. 19 (4): 517–22. doi:10.1016/j.tiv.2004.07.001. PMID15826809.
Saenz-Méndez P, Katz A, Pérez-Kempner ML, Ventura ON, Vázquez M (April 2017). "Structural insights into human microsomal epoxide hydrolase by combined homology modeling, molecular dynamics simulations, and molecular docking calculations". Proteins. 85 (4): 720–730. doi:10.1002/prot.25251. PMID28120429. S2CID9772104.
Lacourciere GM, Armstrong RN (November 1993). "The catalytic mechanism of microsomal epoxide hydrolase involves an ester intermediate". Journal of the American Chemical Society. 115 (22): 10466–10467. doi:10.1021/ja00075a115.
Oesch F (May 1973). "Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 3 (5): 305–40. doi:10.3109/00498257309151525. PMID4584115.
Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN (September 1987). "Leukotrienes and lipoxins: structures, biosynthesis, and biological effects". Science. 237 (4819): 1171–6. Bibcode:1987Sci...237.1171S. doi:10.1126/science.2820055. PMID2820055.
Zhu QS, Xing W, Qian B, von Dippe P, Shneider BL, Fox VL, Levy D (July 2003). "Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1638 (3): 208–16. doi:10.1016/s0925-4439(03)00085-1. PMID12878321.
Zusterzeel PL, Rütten H, Roelofs HM, Peters WH, Steegers EA (February 2001). "Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress". Placenta. 22 (2–3): 213–9. doi:10.1053/plac.2000.0606. PMID11170826.
Azzato EM, Chen RA, Wacholder S, Chanock SJ, Klebanoff MA, Caporaso NE (January 2010). "Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations". Pharmacogenetics and Genomics. 20 (1): 58–63. doi:10.1097/fpc.0b013e328334b6a3. PMID19952982. S2CID29336596.
Smith CA, Harrison DJ (August 1997). "Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema". Lancet. 350 (9078): 630–3. doi:10.1016/s0140-6736(96)08061-0. PMID9288046. S2CID23974600.
Marowsky A, Burgener J, Falck JR, Fritschy JM, Arand M (June 2009). "Distribution of Soluble and Microsomal Epoxide Hydrolase in the Mouse Brain and Its Contribution to Cerebral Epoxyeicosatrienoic Acid Metabolism". Neuroscience. 163 (2): 646–661. doi:10.1016/j.neuroscience.2009.06.033. PMID19540314. S2CID25808698.
Lewis DF, Lake BG, Bird MG (June 2005). "Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity". Toxicology in Vitro. 19 (4): 517–22. doi:10.1016/j.tiv.2004.07.001. PMID15826809.
Saenz-Méndez P, Katz A, Pérez-Kempner ML, Ventura ON, Vázquez M (April 2017). "Structural insights into human microsomal epoxide hydrolase by combined homology modeling, molecular dynamics simulations, and molecular docking calculations". Proteins. 85 (4): 720–730. doi:10.1002/prot.25251. PMID28120429. S2CID9772104.
Oesch F (May 1973). "Mammalian epoxide hydrases: inducible enzymes catalysing the inactivation of carcinogenic and cytotoxic metabolites derived from aromatic and olefinic compounds". Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 3 (5): 305–40. doi:10.3109/00498257309151525. PMID4584115.
Samuelsson B, Dahlén SE, Lindgren JA, Rouzer CA, Serhan CN (September 1987). "Leukotrienes and lipoxins: structures, biosynthesis, and biological effects". Science. 237 (4819): 1171–6. Bibcode:1987Sci...237.1171S. doi:10.1126/science.2820055. PMID2820055.
Zhu QS, Xing W, Qian B, von Dippe P, Shneider BL, Fox VL, Levy D (July 2003). "Inhibition of human m-epoxide hydrolase gene expression in a case of hypercholanemia". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1638 (3): 208–16. doi:10.1016/s0925-4439(03)00085-1. PMID12878321.
Zusterzeel PL, Rütten H, Roelofs HM, Peters WH, Steegers EA (February 2001). "Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress". Placenta. 22 (2–3): 213–9. doi:10.1053/plac.2000.0606. PMID11170826.
Azzato EM, Chen RA, Wacholder S, Chanock SJ, Klebanoff MA, Caporaso NE (January 2010). "Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations". Pharmacogenetics and Genomics. 20 (1): 58–63. doi:10.1097/fpc.0b013e328334b6a3. PMID19952982. S2CID29336596.
Smith CA, Harrison DJ (August 1997). "Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema". Lancet. 350 (9078): 630–3. doi:10.1016/s0140-6736(96)08061-0. PMID9288046. S2CID23974600.
Marowsky A, Burgener J, Falck JR, Fritschy JM, Arand M (June 2009). "Distribution of Soluble and Microsomal Epoxide Hydrolase in the Mouse Brain and Its Contribution to Cerebral Epoxyeicosatrienoic Acid Metabolism". Neuroscience. 163 (2): 646–661. doi:10.1016/j.neuroscience.2009.06.033. PMID19540314. S2CID25808698.
Saenz-Méndez P, Katz A, Pérez-Kempner ML, Ventura ON, Vázquez M (April 2017). "Structural insights into human microsomal epoxide hydrolase by combined homology modeling, molecular dynamics simulations, and molecular docking calculations". Proteins. 85 (4): 720–730. doi:10.1002/prot.25251. PMID28120429. S2CID9772104.
Azzato EM, Chen RA, Wacholder S, Chanock SJ, Klebanoff MA, Caporaso NE (January 2010). "Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations". Pharmacogenetics and Genomics. 20 (1): 58–63. doi:10.1097/fpc.0b013e328334b6a3. PMID19952982. S2CID29336596.
Smith CA, Harrison DJ (August 1997). "Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema". Lancet. 350 (9078): 630–3. doi:10.1016/s0140-6736(96)08061-0. PMID9288046. S2CID23974600.
Marowsky A, Burgener J, Falck JR, Fritschy JM, Arand M (June 2009). "Distribution of Soluble and Microsomal Epoxide Hydrolase in the Mouse Brain and Its Contribution to Cerebral Epoxyeicosatrienoic Acid Metabolism". Neuroscience. 163 (2): 646–661. doi:10.1016/j.neuroscience.2009.06.033. PMID19540314. S2CID25808698.